STOCK-BASED COMPENSATION (Tables)
|
9 Months Ended |
Sep. 30, 2025 |
| Share-Based Payment Arrangement [Abstract] |
|
| Schedule of Fair Values of Stock Options Granted and Assumptions Used in Black-Scholes Model |
The weighted average fair value of stock options granted, and the assumptions used for the Black-Scholes option pricing model were as follows:
| | | | | | | | | | | | | | | | | Nine Months Ended September 30, | | | 2025 | | 2024 | | Weighted average fair value of stock options granted | | $ | 1.84 | | | $ | 11.59 | | | Assumptions: | | | | | | Risk-free interest rate | | 3.6% - 4.1% | | 4.5% | | Expected volatility | | 106.2% - 110.5% | | 99.8% - 102.5% | | Expected term (in years) | | 5.3 - 6.0 | | 5.0 - 5.5 |
|
| Schedule of Information on Stock Option Activity |
Information on stock option activity is as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Options Exercisable | | Weighted Average Exercise Price Per Share | | Options Outstanding | | Weighted Average Exercise Price Per Share | | Balance as of December 31, 2024 | | 127,267 | | $ | 316.92 | | | 572,264 | | $ | 75.44 | | | Granted | | — | | — | | | 861,426 | | 2.23 | | | Vested | | 116,272 | | 5.77 | | | — | | — | | | Exercised | | — | | — | | | — | | — | | | Expired | | (8,834) | | 369.25 | | | (8,834) | | 369.25 | | | Forfeited | | — | | — | | | (41,000) | | 5.75 | | | Balance as of September 30, 2025 | | 234,705 | | $ | 160.81 | | | 1,383,856 | | $ | 30.05 | |
|
| Schedule of Stock-Based Compensation Expense |
Stock-based compensation expense related to stock option awards is as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | In Thousands | | 2025 | | 2024 | | 2025 | | 2024 | | Stock-based compensation expense | | $ | 314 | | | $ | 78 | | | $ | 859 | | | $ | 346 | |
Stock-based compensation expense related to RSAs is as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | In Thousands | | 2025 | | 2024 | | 2025 | | 2024 | | Stock-based compensation expense | | $ | 1,101 | | | $ | 2,418 | | | $ | 4,137 | | | $ | 7,274 | |
Stock-based compensation expense related to RSUs is as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | In Thousands | | 2025 | | 2024 | | 2025 | | 2024 | | Stock-based compensation expense | | $ | 471 | | | $ | 191 | | | $ | 1,367 | | | $ | 410 | |
Certain condensed consolidated statement of operations amounts were as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | In Thousands | | 2025 | | 2024 | | 2025 | | 2024 | | Stock-based compensation expense: | | | | | | | | | | Research and development | | $ | 556 | | | $ | 807 | | | $ | 2,177 | | | $ | 2,467 | | | Selling, general, and administrative | | 1,330 | | | 1,880 | | | 4,186 | | | 5,563 | | | Total | | $ | 1,886 | | | $ | 2,687 | | | $ | 6,363 | | | $ | 8,030 | |
|
| Schedule of Nonvested Share Activity |
Information on RSA activity is as follows: | | | | | | | | | | | | | | Restricted Stock Awards | | Weighted Average Grant Date Fair Value | | Unvested balance as of December 31, 2024 | 274,058 | | $ | 31.50 | | | Granted | — | | — | | | Vested | (135,621) | | 31.50 | | | Forfeited | (23,086) | | 31.50 | | | Unvested balance as of September 30, 2025 | 115,351 | | $ | 31.50 | |
Information on RSU activity is as follows: | | | | | | | | | | | | | | Restricted Stock Units | | Weighted Average Grant Date Fair Value | | Unvested balance as of December 31, 2024 | 779,861 | | $ | 7.62 | | | Granted | 924,013 | | 1.90 | | | Vested | (100,603) | | 11.33 | | | Forfeited | (36,570) | | 5.75 | | | Unvested balance as of September 30, 2025 | 1,566,701 | | $ | 4.05 | |
|
| Schedule of Grant Date Fair Value of Awards Vested |
The total fair value of RSAs that vested is as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | In Thousands | | 2025 | | 2024 | | 2025 | | 2024 | | Fair value of shares vested | | $ | 51 | | | $ | 511 | | | $ | 267 | | | $ | 3,230 | |
The total fair value of RSUs that vested is as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | In Thousands | | 2025 | | 2024 | | 2025 | | 2024 | | Fair value of shares vested | | $ | 86 | | | $ | — | | | $ | 209 | | | $ | 629 | |
|